Upcoming Events

The scientific program will cover various aspects of CRISPR biology ranging from genetics, biochemistry, structural biology, ecology, evolution and applications. The scientific part of the meeting is planned for June 28 to 30. We hope to welcome you in Würzburg June 27 at the evening reception. A group activity is being planned for July 1.

The 2023 Advancing Gene Therapy conference will be held in The Westin Walthum, MA. The meeting will provide conference attendees updates on recent gene therapy innovations from vector designs to product launch. Drivers of these advances will be discussed including the rapid pace of change from biotechnology, pharmaceutical, manufacturing and CROs with preclinical, non-clinical and trial expertise. In addition, the summit covers emerging and related fields including Gene Editing & CRISPR, Cell Therapies, Gene Therapy for Cancer, Immunotherapy, Rare diseases, Blood Disorders, Neurological Disorders, Toxicology Studies, advances in manufacturing, regulatory and medical affairs, Commercialization Strategies, Business Models and Market Access.

Retinal photoreceptor cells provide the critical first steps in vision, transducing incident photons into changes in membrane potential relayed via neural circuits to higher visual centers. Research on photoreceptors and their supporting epithelium, the retinal pigment epithelium (RPE), is not only essential for understanding how we see, but it has also advanced knowledge in areas such as G protein signaling, neurophysiology, and protein structure and function. In addition, fundamental photoreceptor and RPE research has been essential for new insights in the pathobiology of vision loss; blinding diseases like retinitis pigmentosa and macular degeneration result from photoreceptor degeneration that typically first appears as defects in cell biological and physiological mechanisms of the photoreceptors and/or the adjacent RPE.